WORK Medical Technology Group LTD - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of November 2025 for WORK Medical Technology Group LTD, a foreign private issuer headquartered in Hangzhou, China. The report addresses the Company's status regarding Nasdaq listing compliance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory compliance update and does not contain financial performance data.
Material Changes
The primary material change is the resolution of a Nasdaq listing deficiency. The Company previously received a deficiency letter on April 7, 2025, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. After receiving an initial 180-day compliance period and a subsequent extension until April 6, 2026, the Company successfully regained compliance.
Guidance, Outlook, and Risks
On November 4, 2025, Nasdaq confirmed the Company regained compliance by maintaining a minimum closing bid price of $1.00 or greater for 10 consecutive business days (October 10, 2025, to November 3, 2025). The matter is now closed. No forward-looking guidance, management commentary on operations, or new risk factors were disclosed in this filing.
Investor Verification Checklist
- Verify the current trading price of Class A Ordinary Shares to ensure continued compliance with the $1.00 minimum bid requirement.
- Confirm the Company's stock is actively trading on Nasdaq without suspension.
- Review subsequent filings for any new deficiency notices or changes in listing status.